Agios

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agios and other ETFs, options, and stocks.

About AGIO

Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology.

CEO

Brian M. Goff

CEOBrian M. Goff

Employees

488

Employees488

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2007

Founded2007

Employees

488

Employees488

AGIO Key Statistics

Market cap

2.14B

Market cap2.14B

Price-Earnings ratio

3.33

Price-Earnings ratio3.33

Dividend yield

—

Dividend yield—

Average volume

984.21K

Average volume984.21K

High today

—

High today—

Low today

—

Low today—

Open price

$36.43

Open price$36.43

Volume

0.00

Volume0.00

52 Week high

$62.58

52 Week high$62.58

52 Week low

$23.42

52 Week low$23.42

AGIO News

TipRanks 5d

Agios Pharma’s CAO Makes a Significant Stock Sale!

New insider activity at Agios Pharma ( (AGIO) ) has taken place on September 9, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50%...

Simply Wall St 6d

Can Increased FDA Scrutiny Alter Agios Pharmaceuticals' Risk Management Narrative?

Earlier this month, Agios Pharmaceuticals announced that the U.S. FDA extended the review period for the supplemental New Drug Application for PYRUKYND® in both...

Analyst ratings

63%

of 8 ratings

Buy

62.5%

Hold

37.5%

Sell

People also own

Based on the portfolios of people who own AGIO. This list is generated using Robinhood data, and it’s not a recommendation.